Eli Lilly starts late-stage study of arthritis drug in COVID-19 patients
June 15, 2020 at 07:01 AM EDT
U.S. drugmaker Eli Lilly and Co said on Monday it has started a late-stage trial testing its rheumatoid arthritis drug Olumiant in patients hospitalized with COVID-19.